Vol. 29.S3 December 2024 | Annals of Hepatology

Abstracts of the 2024 Annual Meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)

Ann Hepatol. 2024;29 Supl 3: 101595

Full text access

Share

EDITORIAL BOARD

Ann Hepatol. 2024;29 Supl 3: 101768

Full text access

Share

O-1 SIMULTANEOUS LIVER-KIDNEY TRANSPLANTATION OUTCOMES IN LATIN AMERICA

Jorge Carlos Martinez Morales, Valeria Descalzi, Elodie Hyppolito, Adriana Varon, Alina Zerega, Pedro Marin-Castro, Graciela Elia Castro Narro, Josefina Pages, ... Sebastián Marciano

Ann Hepatol. 2024;29 Supl 3: 101596

Full text access

Share

O2- CHARACTERIZATION OF STEATOTIC LIVER DISEASE AND THE ROLE OF GENETIC BACKGROUND IN LATIN AMERICA

LUIS ANTONIO DÍAZ PIGA, Carolina Aguilera, Gustavo Ayares, Francisco Idalsoaga, Mauricio Pizarro, Fernando Javier Barreyro, Sebastián Marciano, Jorge Martínez Morales, ... Juan Pablo Arab

Ann Hepatol. 2024;29 Supl 3: 101597

Full text access

Share

O3- RECOMPENSATION IN PATIENTS WITH CIRRHOSIS PRIOR TO FIRST LINE SYSTEMIC THERAPY IS ASSOCIATED WITH SIMILAR SURVIVAL OUTCOMES COMPARED TO COMPENSATED CIRRHOSIS

FEDERICO PIÑERO, Margarita Anders, Carla Bermúdez, Diego Arufe, Adriana Varón, Ana Palazzo, Jorge Rodriguez, Oscar Beltrán, ... Manuel Mendizabal

Ann Hepatol. 2024;29 Supl 3: 101598

Full text access

Share

OP-1 LONG-TERM EFFICACY AND SAFETY OF OPEN-LABEL SELADELPAR TREATMENT IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: INTERIM 2-YEAR RESULTS FROM THE ASSURE STUDY

Palak J. Trivedi, Cynthia Levy, Kris V. Kowdley, Stuart C. Gordon, Christopher L. Bowlus, Maria Carlota Londoño Hurtado, Gideon M. Hirschfield, Aliya F. Gulamhusien, ... Charles A. McWherter

Ann Hepatol. 2024;29 Supl 3: 101599

Full text access

Share

OP-2 WILSON DISEASE (WD) DIAGNOSIS WITH NEXT-GENERATION SEQUENCING (NGS) IN CLINICAL PRACTICE: A PILOT STUDY

Marta Mitiko Deguti, Michele Soares Gomes Gouvêa, Debora Raquel Benedita Terrabuio, Thiago Ferreira Araújo, Gilda Porta, Egberto Reis Barbosa, Eduardo Luiz Rachid Cançado

Ann Hepatol. 2024;29 Supl 3: 101600

Full text access

Share

OP-3 ASSESSING TREATMENT ELIGIBILITY EXPANSION UNDER THE 2024 WHO GUIDELINES FOR CHRONIC HEPATITIS B

Manuel Mendizabal, Constanza D Sabate, Esteban Gonzalez Ballerga, Fernando Gruz, Ezequiel Ridruejo, Alejandro Soza, Jaime Poniachik, Grace Vergara, ... Sebastian Marciano

Ann Hepatol. 2024;29 Supl 3: 101601

Full text access

Share

OP- 4 EPIDEMIOLOGY OF PRIMARY BILIARY CHOLANGITIS IN LATIN AMERICA: PRELIMINARY RESULTS FROM ALLATIN COHORT

Guilherme Grossi Lopes Cançado, Rafael Theodoro, Ezequiel Ridruejo, Lorena Castro Solari, Cristiane Alves Villela-Nogueira, Pablo Andres Coste Murillo, Harlim Rodríguez, Carlos Benítez Gajardo, ... Claudia Alves Couto

Ann Hepatol. 2024;29 Supl 3: 101602

Full text access

Share

OP-5 ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) CRITERIA IN ALCOHOL-ASSOCIATED HEPATITIS: IMPLICATIONS FOR LIVER TRANSPLANTATION

LUIS ANTONIO DÍAZ PIGA, Paula Huerta, Renata Farias, Bastian Alcayaga, Francisco Idalsoaga, Gustavo Ayares, Jorge Arnold, María Ayala-Valverde, ... Juan Pablo Arab

Ann Hepatol. 2024;29 Supl 3: 101603

Full text access

Share

OP-6 EVALUATION OF THE HEPATOPROTECTIVE ACTIVITY OF Flourensia cernua AND ITS IMPACT ON THE AEROBIC INTESTINAL MICROBIOTA IN A VALPROIC ACID-INDUCED DAMAGE MODEL IN WISTAR RATS

Liliana Torres González, José Miguel De la Rosa García, Jorge Martín Llaca Díaz, Lorena Salazar Cavazos, Humberto Rodríguez Rocha, Aracely García García, Catalina Leos Rivas, Veronica Mayela Rivas Galindo, ... Paula Cordero Pérez

Ann Hepatol. 2024;29 Supl 3: 101604

Full text access

Share

OP-7 Further exploration of differences between lean and non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) in Latino subjects: PNPLA3 frequency and lipidomic profiles

MARIA AYALA VALVERDE, Jorge Arnold Alvarez, Gustavo Ayares, Francisco Barrera, Daniel Cabrera, Luis Antonio Diaz, Juan Pablo Arab, Ibon Martinez-Arranz, ... Marco Arrese

Ann Hepatol. 2024;29 Supl 3: 101605

Full text access

Share

OP-8 SECOND LINE THERAPY IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND INADECUATE RESPONSE: ARE WE CHOOSING THE RIGHT TARGET POPULATION FOR CLINICALS TRIALS?

Daniela De La Viña, Natalia Sobenko, Eduardo Mullen, Ignacio Lucero, Juan Carlos Bandi, Maria Alejandra Villamil

Ann Hepatol. 2024;29 Supl 3: 101606

Full text access

Share

OP-9 Assessing the Burden and Budget Impacts of HCV Elimination Strategies in Uruguay Using Decision-Analytic Modeling

Victoria Mainardi Rial, Daniela Olivari, Solange Gerona, Alec Aron, Huaiyang Zhong, Jagpreet Chhatwal, Lindsey Hiebert, John Ward

Ann Hepatol. 2024;29 Supl 3: 101607

Full text access

Share

OP- 10 - NON-STEROIDAL ANTI-INFLAMMATORY DRUGS: A COMPARATIVE ANALYSIS BETWEEN THE SPANISH AND LATINDILI NETWORKS

FERNANDO BESSONE, Ismael Alvarez Alvarez, Nelia Hernandez, Maria Isabel Schinoni, Inmaculada Medina Caliz, Hugo Tanno, Hao Niu, Maria Virginia Reggiardo, ... Raúl Jesus Andrade

Ann Hepatol. 2024;29 Supl 3: 101608

Full text access

Share

OP- 11 Detection Strategy for Patients with Viral Hepatitis Using Laboratory Records of Blood Samples for HBsAg and HCV Antibodies: PANRELINK

Fernando Cairo, Lucia Navarro, Nicolas Dominguez, Ignacio Roca, Omar Galdame, Laura Gonzalez, Lucia Guillen, Stella Loudet, Manuel Barbero

Ann Hepatol. 2024;29 Supl 3: 101609

Full text access

Share

O-12 DECIPHERING WILSON'S DISEASE IN COSTA RICA: AN INNOVATIVE GENETIC APPROACH

Danny Alvarado, Jorge Andres Herrera Corrales, Mildred Jimenez, Karina Hidalgo, Fernanda Vasquez, Francisco Vargas, Jorge Vargas, Francisco Hevia Urrutia

Ann Hepatol. 2024;29 Supl 3: 101610

Full text access

Share

OP-13 CHOLANGIOCARCINOMA IN LATIN AMERICA: A MULTICENTER OBSERVATIONAL STUDY ALERTS ON ETHNICAL DISPARITIES IN TUMOR PRESENTATION AND OUTCOME

Leonardo G Da Fonseca, Laura Izquierdo Sanchez, Pedro H Hashizume, Yanina Carlino, Estefanía Liza Baca, Cristina Zambrano, Santiago Sepulveda, Andrea Bolomo, ... Jesus M Banales

Ann Hepatol. 2024;29 Supl 3: 101611

Full text access

Share

OP- 14 ENHANCED MUSCLE MASS MITIGATES MASLD IN MYOSTATIN KNOCKOUT MICE WITHOUT IMPACTING EXERCISE PERFORMANCE

Daniel Cabrera Garcia, Faride Saud Zapura, Loreto Aguilar Barria, Marco Arrese, Luis Antonio Díaz, Juan Pablo Arab, Lisbell Estrada, Claudio Cabello Verrugio, ... Marcelo Andia

Ann Hepatol. 2024;29 Supl 3: 101612

Full text access

Share

OP- 15 OUTCOME OF PREGNANCIES IN A SERIES OF WILSON DISEASE PATIENTS

Marta Mitiko Deguti, Debora Raquel Benedita Terrabuio, Fabiana Cordeiro Araújo, Gilda Porta, Egberto Reis Barbosa, Eduardo Luiz Rachid Cançado

Ann Hepatol. 2024;29 Supl 3: 101613

Full text access

Share

OP-16 FREQUENCY OF ATP7B GENE MUTATIONS IN A BRAZILIAN COHORT OF PATIENTS WITH WILSON'S DISEASE

Maria Chiara Chindamo, Carla C. Judice, Marcia Angélica Bonilha Valladares, Bruno Pereira Ribeiro da Rocha, Eliane Almeida do Vale, Aline Moura Ferraz Pereira, Ubiratan Cassano Santos, Andreia Silva Evangelista, ... Renata de Mello Perez

Ann Hepatol. 2024;29 Supl 3: 101614

Full text access

Share

P- 1 DEVELOPMENT OF LENTIVIRAL VECTORS FOR INHIBITION OF HEPATITIS B VIRUS, VIA SMALL INTERFERING RNA

Giovana Angelice Paula, Pedro Henrique da Conceição Roque, Rafaela de Sousa Moraes Pereira, Vanessa Salete de Paula, Fábio Luís Monteiro Lima, Lendel da Costa Correia, Amilcar Tanuri, Elen de Souza Mello, ... Bárbara do Lago Vieira

Ann Hepatol. 2024;29 Supl 3: 101615

Full text access

Share

P-2 RECAM VS. RUCAM: ADVANCING THE DIAGNOSIS OF IDIOSYNCRATIC DILI WITH A REVISED ELECTRONIC APPROACH.

Sara Pillajo, Daniela Chiodi, Ximena Pazos, Adriana Sánchez, Inmaculada Medina-Cáliz, Fernando Bessone, María Isabel Lucena, Nelia Hernandez

Ann Hepatol. 2024;29 Supl 3: 101616

Full text access

Share

P-3 FACTORS ASSOCIATED WITH AN IMPROVEMENT IN SEQUENTIAL LIVER STIFFNESS MEASURES BY TRANSIENT ELASTOGRAPHY IN MASLD PATIENTS WITH PREDIABETES AND TYPE 2 DIABETES.

Lorrane Viana Santos, Claudia Regina Lopes Cardoso, Gil Fernando Salles, Ana Carolina Cardoso, Cristiane Villela-Nogueira, Nathalie Carvalho Leite

Ann Hepatol. 2024;29 Supl 3: 101617

Full text access

Share

P-4 HYPOTHERMIC OXYGENATED PERFUSION USING AN ECMO DEVICE IN LIVER TRANSPLANTATION: AN ANALYSIS OF THE FIRST 100 CASES AT A CHILEAN PUBLIC HOSPITAL

FRANCISCA MAGDALENA MARTÍNEZ VENEZIAN, Elizabeth Rivas, Valeria Galaz, Valentina Castillo, Julio Benitez, Edmundo Martinez, Rodrigo Wolff, Blanca Norero, ... Rolando Rebolledo

Ann Hepatol. 2024;29 Supl 3: 101618

Full text access

Share

P-5 A LARGE REGISTER OF LIVER STIFFNESS AND STEATOSIS BY TRANSIENT ELASTOGRAPHY IN METABOLIC ASSOCIATED STEATOTIC LIVER DISEASE – THE FIRST STEP FOR AN ADEQUATE PATIENT ALLOCATION

Ana Carolina Cardoso, João Marcello De Araújo Neto, Pedro Miguel Mattos Nogueira, Nathalie Carvalho Leite, Cristiane Villela-Nogueira

Ann Hepatol. 2024;29 Supl 3: 101619

Full text access

Share

P-6 CORRELATION BETWEEN CONNECTIVE TISSUE GROWTH FACTOR (CTGF) AND FIBROSIS DEGREE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC)

Cristian Yamín Sánchez Sánchez, Diego Fernando Abendaño Rivera, Viridiana López Ladrón De Guevara, María Argentina Díaz Castro, Fátima Higuera de da Tijera, Carolina Guzmán Arriaga, Ángel Daniel Santana Vargas, José Luis Pérez Hernández

Ann Hepatol. 2024;29 Supl 3: 101620

Full text access

Share

P-7 EPIDEMIOLOGY OF AUTOIMMUNE HEPATITIS IN LATIN AMERICA: PRELIMINARY RESULTS FROM ALLATIN COHORT

Guilherme Grossi Lopes Cançado, Ludmila Resende Guedes, Ezequiel Ridruejo, Lorena Castro Solari, Debora Raquel Benedita Terrabuio, Emilia Vera, Harlim Rodríguez, Pablo Andres Coste Murillo, ... Claudia Alves Couto

Ann Hepatol. 2024;29 Supl 3: 101621

Full text access

Share

P-8 TRENDS IN ALCOHOL-ASSOCIATED CIRRHOSIS IN CHILE: A POPULATION STUDY BETWEEN 2001 TO 2020.

Ignacio Alarcón, Susana Mondschein, Alvaro Urzua, Juan ROBLERO CUM

Ann Hepatol. 2024;29 Supl 3: 101622

Full text access

Share

P-9 SURVIVAL ANALYSIS OF A BRAZILIAN COHORT OF PATIENTS WITH WILSON DISEASE

Maria Chiara Chindamo, Vivian Rotman, Nathalia Carrano Eduardo de Castro, Debora Canoilas, Ubiratan Cassano Santos, Andreia Silva Evangelista, Fernanda Luiza Valladares Calçado, Leticia Cancella Nabuco, Renata de Mello Perez

Ann Hepatol. 2024;29 Supl 3: 101623

Full text access

Share

P-10 SEROPREVALENCE OF CHRONIC HEPATITIS C INFECTION AND VIROLOGICAL CURE WITH A DAILY ADMINISTRATION SYSTEM OF NS3/4A PROTEASE INHIBITOR AND NS5A INHIBITOR IN IMPRISONED PATIENTS.

VÍCTOR MANUEL FONG FLORES, Omar Perez Carreon, Andres Flores Gomez, Andres Murillo Gallo, Alfredo Ojeda Garmendia, Mariana Marquez

Ann Hepatol. 2024;29 Supl 3: 101624

Full text access

Share

P-11 REAL-WORLD DATA WITH PANGENOTYPIC DIRECT-ACTING ANTIVIRALS IN LATINAMERICA: PRELIMINARY RESULTS OF THE SVR10K STUDY

Mario Alvares da Silva, Fatima Higuera de la Tijera, Miguel Castruita Garcia, Oscar Beltran Galvis, Ming Lung Yu, Soo Aleman, Grace Lai-Hung Wong, Javier Garcia Samaniego, ... Yu Jun Wong

Ann Hepatol. 2024;29 Supl 3: 101625

Full text access

Share

P-12 METHYL GROUP DONOR SUPPLEMENTATION IN A MetALD MODEL: REGULATION OF GUT MICROBIOTA AND METABOLIC PARAMETERS

Carolina Díaz Canul, Angel Omar Vázquez Esqueda, Rebeca Rosas Campos, Rebeca Escutia Gutiérrez, Natalia Gómez Gómez, Monica Ibarra Hernández, Marina Galicia Moreno, Juan Armendáriz Borunda, Ana Sandoval Rodriguez

Ann Hepatol. 2024;29 Supl 3: 101626

Full text access

Share

P-13 EVALUATION OF UNDIAGNOSED ALCOHOLIC LIVER DISEASE IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE USING THE ANI SCORE

Carlos Alventosa Mateu, Mercedes Latorre Sánchez, Inmaculada Castelló Miralles, Benjamín Climent Díaz, Juan José Urquijo Ponce, Moisés Diago Madrid

Ann Hepatol. 2024;29 Supl 3: 101627

Full text access

Share

P-14 DETECTION OF CIRRHOSIS DUE TO ALPHA-1 ANTITRYPSIN DEFICIENCY IN ADULTS: PHENOTYPE STUDY IN COSTA RICA

Fernanda Vásquez Carit, Francisco Hevia Urrutia, Jorge Vargas Madrigal, Mildred Jiménez Hernández, Natassia Camacho Matamoros, Danny Alvarado Romero, Jorge Herrera Corrales

Ann Hepatol. 2024;29 Supl 3: 101628

Full text access

Share

P- 15 GENETIC AND CLINICAL CHARACTERISTICS IN LEAN MASLD PATIENTS WITH AND WITHOUT CIRRHOSIS IN LATINOAMERICAN POPULATION

Karina Sato Espinoza, Javier Díaz Ferrer, Domingo Balderramo, Jhon Prieto Ortiz, Marco Arrese, Enrique Carrera Estupiñan, Angelo Zamban De Mattos, Jose Debes

Ann Hepatol. 2024;29 Supl 3: 101629

Full text access

Share

P-16 UNLOCKING S-PINDOLOL'S POTENTIAL FOR MASLD: BENEFICIAL EFFECTS ON MUSCLE MASS AND FUNCTION AND LIVER HISTOLOGY IN WESTERN- DIET FED MICE

Daniel Cabrera, Loreto Aguilar, Faride Saud, Lisbell Estrada, Marcelo Andia, Marco Arrese, Juan Pablo Arab, Luis Antonio Diaz, ... Claudio Cabello-Verrugio

Ann Hepatol. 2024;29 Supl 3: 101630

Full text access

Share

P-17 AMIKACIN USE AND RISK OF NEPHROTOXICITY IN PATIENTS WITH LIVER CIRRHOSIS HOSPITALIZED FOR SEPSIS

Alonso Saez, Carlos Padilla, Daniela Simian, Juan Medel, Gabriel Mendez, María Gómez, Alvaro Urzúa, Juan Pablo Roblero, Jaime Poniachik

Ann Hepatol. 2024;29 Supl 3: 101631

Full text access

Share

P-18 ANTI-HBC POSITIVITY IS AN INDEPENDENT PREDICTIVE FACTOR FOR HCC DEVELOPMENT AND SHOULD BE INCORPORATED TO THE HCC RISK SCORE PREDICTION MODEL IN ADVANCED FIBROSIS

Marcus Vinicius de Acevedo Garcia Gomes, Diogo Delgado Dotta, Manuella Andrade Oliveira Sobral, Isabela Bodaczny Taliberti, Alexandre Belucci Trazzi, Eduardo Pombo Nascimento, Betania da Silva Rocha, Patricia Momoyo Yoshimura Zitelli, ... Mario Guimaraes Pessoa

Ann Hepatol. 2024;29 Supl 3: 101632

Full text access

Share

P-19 ASSOCIATION OF TM6SF2 GENE POLYMORPHISMS WITH CARDIOVASCULAR RISK IN PATIENTS WITH METABOLIC DYSFUNCTION–ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN A HISPANIC ADULT POPULATION

LUISA FERNANDA SANTOS CUERVO, Maria Claudia Noguera Santamaria, Carlos Andres Ortiz Trujillo, Fernando Suarez Obando, Adriana Varon Puerta

Ann Hepatol. 2024;29 Supl 3: 101633

Full text access

Share

P-20 HIGH PREVALENCE OF CHRONIC HEPATITIS B IN ACHE COMMUNITIES IN THE DEPARTMENT OF CANINDEYU-PARAGUAY

Sebastián Díaz Duba, Marcos Girala Salomon, Guillermo Fernandez, Sara Melgarejo, Karina Riquelme, Sergio Morinigo, Claudia Crovato, Sebastián Burró, ... Jesús Ortiz Villalba

Ann Hepatol. 2024;29 Supl 3: 101634

Full text access

Share

P-21 THE ROLE SP-INDUCED MAST CELL ACTIVATION IN LIVER FIBROSIS

Larissa Aleman Franco, Beatriz Gárate Pérez De Tudela, Bárbara Castro Rebolledo, Elisa Balboa Castillo, Jaime Poniachik Teller, Caroll J Beltrán Muñoz

Ann Hepatol. 2024;29 Supl 3: 101635

Full text access

Share

P-22 URINARY BIOMARKER NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) FOR IDENTIFYING ACUTE KIDNEY INJURY IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS AND CIRRHOSIS

Cristian Yamín Sánchez Sánchez, Diego Fernando Abendaño Rivera, Ximena Elizabeth Cuenca Ávila, Fátima Higuera De La Tijera, Carolina Guzmán Arriaga, Ángel Daniel Santana Vargas, José Luis Pérez Hernández

Ann Hepatol. 2024;29 Supl 3: 101636

Full text access

Share

P-23 PORTAL VEIN THROMBOSIS IS ASSOCIATED WITH HEPATIC DECOMPENSATIONS WITHOUT LIVER STIFFNESS INCREASE IN HEPATOSPLENIC SCHISTOSOMIASIS

Rafael Theodoro, Guilherme Grossi Lopes Cançado, Mateus Jorge Nardelli, Guilherme Augusto Lima Figueira, Carlos Eduardo Franca Vargas, Ludmila Resende Guedes, Fernanda Maria Farage Osório, Luciana Costa Faria, Claudia Alves Couto

Ann Hepatol. 2024;29 Supl 3: 101637

Full text access

Share

P-24 DESCRIPTION OF SERUM MICRORNAS EXPRESSION AMONG INDIVIDUALS WITH VIRAL HEPATITIS AND LONG COVID

Lucas da Silva Lima, Juliana Maul Cardoso, Iolanda Raquel Paulo Ferreira, Luciane Leon Almeida Amado, Otacilio Moreira Da Cruz, Wagner Luis Coelho da Costa Nunes Pimentel, Lia Lewis Laura, Vanessa Salete De Paula, ... Livia Villar Melo

Ann Hepatol. 2024;29 Supl 3: 101638

Full text access

Share

P-25 IMPEDANCE CARDIOGRAPHY AND SPLEEN STIFFNESS MEASUREMENT TO ASSESS THERAPEUTIC RESPONSE IN CIRRHOTIC PATIENTS TREATED WITH NON-CARDIOSELECTIVE BETA-BLOCKERS

Martín Elizondo Barceló, Andreína Tesis Montes, Marcelo Valverde Gómez, Ricardo Armentano Feijoo, Solange Gerona Sangiovanni

Ann Hepatol. 2024;29 Supl 3: 101639

Full text access

Share

P-26 EPIGENETIC MARKS IN PATIENTS WITH SUSTAINED VIRAL RESPONSE TO HCV AND RESIDUAL LIVER FIBROSIS ARE RESTORED BY PROLONGED-RELEASE PIRFENIDONE

Eira Cerda Reyes, Ricardo De la Rosa Bibiano, Ana Sandoval Rodriguez, Rebeca Rosas Campos, Rebeca Escutia Gutiérrez, Ángel Omar Vázquez Esqueda, Stefanny Cornejo Hernández, Alejandro Gutiérrez Átemis, ... Juan Armendáriz Borunda

Ann Hepatol. 2024;29 Supl 3: 101640

Full text access

Share

P-27 OBESITY AND LIVER STEATOSIS IN ADOLESCENTS AND YOUNG ADULTS - RELATED FACTORS AND THE IMPACT OF LIFESTYLE

Fabiana Martins Basilio, Ana Carolina Cardoso, Katia Bloch, Nathalie Leite, Cristiane Villela-Nogueira

Ann Hepatol. 2024;29 Supl 3: 101641

Full text access

Share

P-28 CHARACTERIZATION OF CHRONIC LIVER DISEASE, CIRRHOSIS, AND HEPATOCELLULAR CARCINOMA PROGRESSION IN A COLOMBIAN HEALTH MAINTENANCE ORGANIZATION: A TEN-YEAR RETROSPECTIVE STUDY

Joshua Kock Sierra, Juan Felipe Betancur, Jhon Edward Bolaños, Luz Eugenia Perez, Carlos José Bello, Farley Johanna Gonzalez, Jose Sanabria, Carlos Badillo

Ann Hepatol. 2024;29 Supl 3: 101642

Full text access

Share

P-29 DIFFERENCES IN THE PROGRESSION OF BODY COMPOSITION AND LIVER DAMAGE IN A MURINE MODEL OF METABOLIC SYNDROME: A SEX PERSPECTIVE

Laura Manjarrés, Aline Xavier, Leticia González, Camila Garrido, Flavia Zacconi, Carlos Sing-Long, Marcelo Andia

Ann Hepatol. 2024;29 Supl 3: 101643

Full text access

Share